Artificial Pancreas Market Research Report- Forecast till 2030

Artificial Pancreas Market Research information by control type (threshold suspend device system, non-threshold suspend device system, control-to-range (CTR) system, and control-to-target (CTT) system) by treatment type (insulin only, bi-hormonal, hybrid) and by end users - Forecast till 2030

ID: MRFR/MED/2566-HCR | 110 Pages | Author: Kinjoll Dey | March 2024         

Table of Contents

1. INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2. RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3. MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4. MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

5. GLOBAL ARTIFICIAL PANCREAS MARKET, BY CONTROL TYPE

5.1 THRESHOLD SUSPEND DEVICE SYSTEM

5.2 NON-THRESHOLD SUSPEND DEVICE SYSTEM

5.3 CONTROL-TO-RANGE (CTR) SYSTEM

5.4 CONTROL-TO-TARGET (CTT) SYSTEM

6. GLOBAL ARTIFICIAL PANCREAS MARKET, BY TREATMENT TYPE

6.1 INSULIN ONLY

6.2 BI-HORMONAL

6.3 HYBRID

7. GLOBAL ARTIFICIAL PANCREAS MARKET, BY END USERS

7.1 HOSPITALS AND CLINICS

7.2 RESEARCH

7.3 OTHERS

8. GLOBAL ARTIFICIAL PANCREAS MARKET, BY REGION

8.1 NORTH AMERICA

8.1.1 INTRODUCTION

8.2 EUROPE

8.2.1 INTRODUCTION

8.3 ASIA-PACIFIC

8.3.1 INTRODUCTION

8.4 MIDDLE EAST & AFRICA

8.4.1 INTRODUCTION

9. COMPETITIVE LANDSCAPE

9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS

9.1.1 STRATEGIC PARTNERSHIP

9.1.2 MERGER & ACQUISITION

10. COMPANY PROFILE

10.1 MEDTRONIC

10.1.1 OVERVIEW

10.1.2 PRODUCT OVERVIEW

10.1.3 FINANCIALS

10.1.4 KEY DEVELOPMENTS

10.2 JOHNSON & JOHNSON

10.2.1 OVERVIEW

10.2.2 PRODUCT OVERVIEW

10.2.3 FINANCIALS

10.2.4 KEY DEVELOPMENTS

10.3 BETA BIONICS

10.3.1 OVERVIEW

10.3.2 PRODUCT OVERVIEW

10.3.3 FINANCIALS

10.3.4 KEY DEVELOPMENT

10.4 BIGFOOT BIOMEDICAL

10.4.1 OVERVIEW

10.4.2 PRODUCT OVERVIEW

10.4.3 FINANCIALS

10.4.4 KEY DEVELOPMENTS

10.5 ADMETSYS (PIPELINE PRODUCT ANALYSIS)

10.5.1 OVERVIEW

10.5.2 PRODUCT OVERVIEW

10.5.3 FINANCIALS

10.5.4 KEY DEVELOPMENTS

10.6 ANIMAS CORPORATION

10.6.1 OVERVIEW

10.6.2 PRODUCT OVERVIEW

10.6.3 FINANCIALS

10.6.4 KEY DEVELOPMENTS

10.7 DEFYMED

10.7.1 OVERVIEW

10.7.2 PRODUCT OVERVIEW

10.7.3 FINANCIALS

10.7.4 KEY DEVELOPMENTS

10.8 DEXCOM

10.8.1 OVERVIEW

10.8.2 PRODUCT OVERVIEW

10.8.3 FINANCIALS

10.8.4 KEY DEVELOPMENTS

10.9 INSULET

10.9.1 OVERVIEW

10.9.2 PRODUCT OVERVIEW

10.9.3 FINANCIALS

10.9.4 KEY DEVELOPMENTS

10.10 SEMMA THERAPEUTICS

10.10.1 OVERVIEW

10.10.2 PRODUCT OVERVIEW

10.10.3 FINANCIALS

10.10.4 KEY DEVELOPMENTS

10.11 TYPEZERO TECHNOLOGIES

10.11.1 OVERVIEW

10.11.2 PRODUCT OVERVIEW

10.11.3 FINANCIALS

10.11.4 KEY DEVELOPMENTS

10.12 TANDEM DIABETES CARE

10.12.1 OVERVIEW

10.12.2 PRODUCT OVERVIEW

10.12.3 FINANCIALS

10.12.4 KEY DEVELOPMENTS

10.8 MEDTECH

10.13.1 OVERVIEW

10.13.2 PRODUCT OVERVIEW

10.13.3 FINANCIALS

10.13.4 KEY DEVELOPMENTS

10.14 OTHERS

CONCLUSION

11.1 KEY FINDINGS

11.1.1 FROM CEO’S VIEWPOINT

11.1.2 UNMET NEEDS OF THE MARKET

11.2 KEY COMPANIES TO WATCH

11.3 PREDICTION OF ARTIFICIAL PANCREAS INDUSTRY

12. APPENDIX

Leading companies partner with us for data-driven Insights.
Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid